This event has been postponed until Spring 2022.

Please check back periodically for additional information.

During the week of (Postponed until Spring 2022), the Air Force IR&D Office in concert with DoD’s Biotechnology CoI are staging the 2021 Biotechnology Independent Research and Development (IR&D) Technology Interchange Meeting (TIM). This invitation is open to all industry with IR&D and corporate investments, including large and small businesses, academia, National Labs, and FFRDCs with a signed and certified DD2345 (Military Critical Technical Data Agreement).

Due to current health conditions this will now be an all Virtual Event.

Event Scope

The 2021 Biotechnology IR&D TIM has broad goals to increase awareness, stimulate collaboration, and seek alignment between Industry’s IR&D innovation investments and DoD’s high-priority S&T needs. Leading Subject Matter Experts (SMEs) from the Biotechnology CoI are expected to participate.

Key areas of interest for this TIM are the Biotechnology CoI Subareas of Enhancing Warfighter Systems (EWS) and Optimizing Warfighter Performance (OWP). Both of these subareas have a prime focus on warfighter capabilities and needs.

The taxonomies for this event are listed below:

Planning Schedule

For planning purposes a high level schedule of milestones is being provided. Please note dates listed are subject to change.

Date Activity
TBD Window closes for IR&D Abstract Nominations
TBD Evaluations of IR&D Abstracts are completed
TBD Invitations sent to selected companies to present at the event
TBD Industry provides read-ahead presentation for Govt SMEs
TBD Execute 2021 Biotechnology TIM

Note: This webpage supplements the announcement in -- Future postings of changes and updates including final venue details will only be posted on this page. Therefore, companies are encouraged to check back often.

Many thanks to you for viewing this announcement. We look forward to your favorable consideration to engage in this exciting government-industry technology dialogue! Our nation’s warfighters count on you and your innovation! Any questions should be directed to the Human Systems inbox

Participation Interest

Please send your expression of interest and company’s DD2345 to – Human Systems email inbox. Once your expression of interest is received by our IR&D planning team, you will be sent additional instructions on how to nominate your IR&D projects and corporate investments. In these instructions, we will request you review the technical content of the IR&D projects and corporate investments you intend to nominate and identify the specific line item of the taxonomy. This will aid us in assuring we have the right SMEs to meet with you. Our hope is that the topic nominations provide a clear description of the proposed solution and relevance for the sub-area thrust(s). Please note -- If you do not hear back from the planning team within one week, please resend the original email.


  1. COVID-19 – There are still uncertainties related to the pandemic that may affect the current plan to conduct this event as a face-to-face (F2F) engagement. State restrictions will be monitored closely and all health and safety protocols (masks and physical spacing) will be strictly enforced for an in-person event.
  2. The government is not obligated to enter into a contract with any entity as a result of IR&D collaborations from our dialogue. Data exchanges, as a result of these dialogue activities, follow restrictions of No Foreign Nationals (NOFORN) and International Traffic Arms Regulations (ITAR), and export control restrictions in accordance with Department of Defense Instruction 5230.24, Department of Defense Directive 5230.25, the Arms Export Control Act (Title 22, U.S.C., Sec 2751, et seq.), and/or the Export Administration Act of 1979 (Title 50, U.S.C., App. 2401 et seq.), as amended.
  3. Government technical support contractors may be a part of the team of subject matter experts at the event; therefore, company-to-company Non-Disclosure Agreements may be necessary.
  4. All unclassified company Proprietary Data and Intellectual Property will be treated as Controlled Unclassified Information (CUI). Some information we intend to share may be classified or unclassified and will not be approved for unlimited public release.